Human Microbiome Action
Human Microbiome Action

Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL – a randomised clinical biomarker validation trial

By |2024-06-28T10:51:59+02:00June 28, 2024|Resources|

Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial - (2023)

Comments Off on Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL – a randomised clinical biomarker validation trial
Go to Top